Observe Medical ASA: Receipt of subscription rights in the rights issue by primary insiders and close associates
Reference is made to the stock exchange announcement published by Observe Medical ASA (the "Company") on 22 November 2023, regarding the extraordinary general meeting's approval of the contemplated rights issue raising gross proceeds of up to NOK 55 million (the "Rights Issue"). Reference is further made to the stock exchange announcement published on 24 November 2023 regarding the approval by the Financial Supervisory Authority of Norway (Nw. Finanstilsynet) of the prospectus prepared by the Company for the offer and listing on the Oslo Stock Exchange (Euronext Expand) of up to 211,538,461